Overview

Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers

Status:
Completed
Trial end date:
2017-03-07
Target enrollment:
Participant gender:
Summary
This study has a randomized, evaluator-blinded, vehicle- controlled study to assess the pharmacodynamics of omiganan and omiganan with imiquimod in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Cutanea Life Sciences, Inc.
Maruho Co., Ltd.
Treatments:
Antimicrobial Cationic Peptides
Imiquimod